Founders Capital Management
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1704300
HOUSTON, TX
Position in LCTX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$20,960
-$4,320 QoQ
Shares Held
16,000
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 9 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Founders Capital Management holds $121,159 across 7 Biotechnology names. LCTX ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
1,400 | $38,458 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
2,500 | $24,550 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
This page
|
16,000 | $20,960 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
600 | $18,858 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
300 | $11,703 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
1,667 | $5,667 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
4 | $963 |
All Filings in LCTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,960 | 16,000 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $25,280 | 16,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $20,040 | 12,000 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $20,280 | 12,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,920 | 12,000 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $5,400 | 12,000 | Shares | Sole | 2025-04-08 | |
| 2024-09-30 | $13,650 | 15,000 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $8,000 | 8,000 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $11,840 | 8,000 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $8,720 | 8,000 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $9,440 | 8,000 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $11,280 | 8,000 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $12,000 | 8,000 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $9,360 | 8,000 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $9,040 | 8,000 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $12,640 | 8,000 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $12,320 | 8,000 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $19,600 | 8,000 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $12,524 | 4,970 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $14,164 | 4,970 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $11,679 | 4,970 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $8,747 | 4,970 | Shares | Sole | 2021-01-12 | |
| 2020-03-31 | $4,125 | 4,970 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||